Christine Solbach

Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Carsten Denkert, Sibylle Loibl, Aurelia Noske et al. · Journal of Clinical Oncology · 2009 · 1.8K citations

Life Sciences, Immunology, Oncology +17

Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials

Carsten Denkert, Fenja Seither, Andreas Schneeweiß et al. · The Lancet Oncology · 2021 · 561 citations

Medicine, Cancer Biology, Oncology +16

Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer

Gϋnter von Minckwitz, Holger Eidtmann, Mahdi Rezai et al. · New England Journal of Medicine · 2012 · 531 citations

Medicine, Oncology, Pharmacotherapy +17

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

Achim Rody, Uwe Holtrich, L. Pusztai et al. · Breast Cancer Research · 2009 · 482 citations · Full text

Medicine, Cancer Biology, Oncology +17

A clinically relevant gene signature in triple negative and basal-like breast cancer

Achim Rody, Thomas Karn, Cornelia Liedtke et al. · Breast Cancer Research · 2011 · 336 citations · Full text

Medicine, Cancer Biology, Oncology +17